Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs35733055 | chr14:74517377 | C/T | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs35747962 | chr2:242555080 | G/T | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs35750877 | chr3:53099587 | A/G | 7.69E-6 | 175 | 25.08 | 26.57 | 11.78 | KM Plot |
PCPG | rs35751059 | chr14:74314986 | A/AT | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs35757374 | chr17:50301060 | A/G | 6.47E-5 | 177 | 25.53 | 28.38 | 14.47 | KM Plot |
PCPG | rs35761432 | chr8:121401000 | G/C | 4.06E-6 | 178 | 27.2 | 25.33 | 19.87 | KM Plot |
PCPG | rs35769864 | chr16:89956249 | T/C | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs35770856 | chr10:131987915 | GCA/G | 0 | 174 | 25.53 | 25.33 | 3.17 | KM Plot |
PCPG | rs35772502 | chr3:80592960 | AT/A | 0.000142 | 175 | 19.87 | 24.03 | 27.4 | KM Plot |
PCPG | rs35824492 | chr17:50299079 | G/A | 6.24E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs35835514 | chr14:74433171 | GT/GTT | 5.36E-6 | 172 | 25.28 | 28.47 | 10.3 | KM Plot |
PCPG | rs35837657 | chr16:71491300 | T/C | 0 | 177 | 24.5 | 28.47 | 3.17 | KM Plot |
PCPG | rs35846579 | chr14:74594979 | C/G | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs35853515 | chr16:1699058 | T/TA | 4.84E-5 | 177 | 25.47 | 19.3 | 19.83 | KM Plot |
PCPG | rs35853722 | chr2:24310755 | C/T | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |